Halloween DealsAmazon USHalloween week deals: useful picks before month-endAmazon US: current deals, useful picks and tech finds.Check DealsSlow PC?RecommendedPC slow today? Run a repair scan before it gets worseResolve common Windows issues and optimize system performance.Scan NowHalloween DealsAmazon USOctober picks are moving - compare before checkoutAmazon US: current deals, useful picks and tech finds.See Picks×
FREEDOM251

Freedom251 › Blog › biotechnology

First bacterial galactose oxidase could enable greener drug and food-ingredient chemistry

By Freedom251 Team · · 4 min read

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Researchers at ITQB NOVA have characterized PsGalOx, the first galactose oxidase reported from bacteria. In laboratory experiments, engineered versions were 40 to 1,800 times more efficient than the starting enzyme across different sugars and alcohols, but no industrial process or commercial drug or food ingredient using PsGalOx has yet been reported.

What the researchers discovered

The study, “Engineering a Modular Bacterial Galactose Oxidase through CBM Recombination and Second-Shell Substitutions,” was published in Chem & Bio Engineering on October 11, 2026 (DOI: 10.1021/cbe.6c00167). The team, led by Lígia Martins at Instituto de Tecnologia Química e Biológica António Xavier (ITQB NOVA), identified and engineered PsGalOx as a bacterial platform for oxidizing galactose-related sugars and alcohols.

As an Amazon Associate I earn from qualifying purchases.

Galactose oxidases use molecular oxygen to convert alcohol groups in sugars and other molecules into oxidized products. They can operate under comparatively mild, water-compatible biological conditions. Conventional chemical oxidation often relies on harsher oxidants, higher temperatures and generates waste streams that require treatment.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

The immediate significance is not a finished manufacturing route. It is the addition of a bacterial scaffold that researchers can now adapt for specific pharmaceutical, food, flavor, fragrance and materials intermediates.

How PsGalOx is built and works

A catalytic core with two related binding modules

Well-studied galactose oxidases from fungi generally have a different architecture. PsGalOx contains a catalytic module plus two nearly identical carbohydrate-binding modules. The duplicated modules share approximately 80% sequence identity, yet they do different jobs: one mainly improves binding to sugars, while the other primarily helps the protein remain stable.

That division matters for engineering. A mutation that improves substrate contact may not improve folding or lifetime, and a stability change may not make the active site faster. Treating the modules as interchangeable would therefore obscure which change is responsible for an observed gain.

Oxygen-driven oxidation

In the reaction, the enzyme uses oxygen as the terminal oxidant under mild biological conditions. The product is an oxidized sugar or alcohol that can serve as a chemical intermediate. The precise product, conversion and selectivity depend on the substrate and the enzyme variant; the reported work does not establish one universal reaction for all galactose-derived compounds.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

How the team made a difficult enzyme more usable

  1. Structural prediction: AlphaFold models helped the researchers interpret PsGalOx’s unusual modular structure and identify changes that might improve folding and production. Martins said the enzyme had been “exceptionally difficult to produce in a soluble form” for several years.
  2. Directed evolution: The team introduced mutations and screened thousands of bacterial colonies for improved variants.
  3. Module recombination: Hybrid carbohydrate-binding modules were assembled to combine useful properties from the duplicated regions.
  4. Second-shell substitutions: Additional mutations around, rather than directly in, the most obvious catalytic positions helped improve the engineered enzyme.

A key result was learning to separate expression from catalysis. Early activity increases did not necessarily mean that each enzyme molecule was carrying out chemistry faster. Much of the initial improvement came because host cells produced more enzyme in soluble form. Once that distinction was made, later engineering could target intrinsic catalytic performance rather than treating every activity increase as a faster reaction.

What the reported efficiency range means

Reported result How to interpret it
40- to 1,800-fold improvement The engineered variants were more efficient than the starting PsGalOx across the different sugars and alcohols tested.
One universal multiplier? No. The range covers multiple substrates and does not describe a single improvement that applies to every reaction.
Industrial performance? Not established. The experiments were laboratory tests, not demonstrations in a production reactor.
Approximately 80% sequence identity A comparison between PsGalOx’s duplicated carbohydrate-binding modules, not a market or population statistic.

Why a bacterial scaffold could make oxidation greener

Decision axis Potential advantage of PsGalOx What remains unknown
Oxidant and waste Uses molecular oxygen rather than requiring a stoichiometric harsh oxidant, potentially reducing hazardous by-products. Waste, oxygen-transfer needs and downstream purification at scale have not been reported.
Operating conditions Enzymatic oxidation is designed for mild biological conditions, often compatible with aqueous processing. The optimum pH, temperature, solvent tolerance and operating window for each target substrate are not yet established.
Expression Bacterial production offers a route to soluble enzyme expression and rapid genetic engineering. Manufacturing yield, fermentation cost, formulation and long-term storage stability are unknown.
Substrate scope The platform has demonstrated activity on tested sugars and alcohols and can be evolved toward other molecules. Pharmaceutical, food, fragrance and materials substrates of commercial interest remain future targets.
Scale and economics Laboratory engineering provides a starting point for process development. No industrial reactor data, cost model, productivity figure or commercial product has been published.

What PsGalOx can and cannot do today

Established by the study

  • PsGalOx is the first characterized galactose oxidase from bacteria.
  • Its two related binding modules have distinct binding and stability roles.
  • AlphaFold-guided design, directed evolution and module recombination improved soluble production and laboratory efficiency.
  • Engineered variants showed a 40- to 1,800-fold efficiency increase across the tested substrates.

Not yet demonstrated

  • A finished pharmaceutical active ingredient made with PsGalOx.
  • A commercial food ingredient, flavor or fragrance manufactured with the enzyme.
  • Continuous operation, pilot-scale conversion, enzyme recycling or validated downstream purification.
  • Process economics, environmental accounting or superiority over a named chemical route.

Calling the platform “greener” is therefore a direction for process development, not proof that it has already replaced a commercial oxidation method.

How it fits with earlier enzyme research

PsGalOx expands the available bacterial starting points, but it is not the first example of engineering carbohydrate oxidases. A 2022 study of NagOx, a different enzyme from Ralstonia solanacearum, showed that mutations could alter acceptance of mono- and disaccharides. A 2024 study reported stable, promiscuous engineered galactose oxidases with broader activity. Those studies support the use of directed evolution and computational design; they do not establish that PsGalOx is ready for commercial production.

Rank #4
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Support on Ko-Fi

What happens next

The ITQB NOVA team plans to continue engineering PsGalOx toward substrates of practical interest. The most consequential next tests will be substrate-specific selectivity, turnover at useful concentrations, stability over extended operation, oxygen transfer, recovery and reuse, and performance in a realistic process medium.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

If those hurdles are cleared, the bacterial scaffold could become a platform for making oxidized intermediates under milder conditions. Until then, PsGalOx is best understood as a promising, newly characterized enzyme technology demonstrated at laboratory scale.

Quick Recap

SaleBestseller No. 2
SaleBestseller No. 3
SaleBestseller No. 4
Biochemistry
Biochemistry
$107.51

Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.

biotechnologyenzymesfood ingredientsgreen chemistryPharmaceutical Manufacturingsynthetic biology

Leave a Reply

Your email address will not be published. Required fields are marked *

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Recommended PC Tool
Recommended PC Tool
Windows Errors? Fix Them Before They SpreadFree repair scan
Crashes, No Sound, or Screen Glitches?Free driver scan

Two free Windows tools

One Free Minute Could Fix That PC

Before you go - each of these free tools takes about a minute and tackles what quietly slows a Windows PC down.

Special offer. View Outbyte info, uninstall instructions, EULA, and Privacy Policy.